Cover Image

Editorial: New strategies for reversing cancer therapy resistance

Saved in:

Bibliographic Details
Main Authors:	Yue Du (Author), Xiujun Liu (Author), Lulu Wang (Author), Shengxi Chen (Author)
Format:	Book
Published:	Frontiers Media S.A., 2024-04-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Therapy resistance in neuroblastoma: Mechanisms and reversal strategies
by: Xia Zhou, et al.
Published: (2023)

Therapy resistance in prostate cancer: mechanism, signaling and reversal strategies
by: Neha Thakur, et al.
Published: (2024)

Drug resistance mechanism and reversal strategy in lung cancer immunotherapy
by: Yishi Xu, et al.
Published: (2023)

Editorial: Adaptive immune resistance in cancer therapy
by: Aimin Jiang, et al.
Published: (2023)

Natural products reverse cancer multidrug resistance
by: Jia-Yu Zou, et al.
Published: (2024)

Phenethylisothiocyanate Potentiates Platinum Therapy by Reversing Cisplatin Resistance in Cervical Cancer
by: Elizabeth Mahapatra, et al.
Published: (2022)

Editorial: Epigenetic regulation and therapy resistance in cancer
by: Yongxia Zhu, et al.
Published: (2023)

Editorial: Chemo-Radiation-Resistance in Cancer Therapy
by: Xiaoping Lin, et al.
Published: (2022)

Berberine Maintains the Neutrophil N1 Phenotype to Reverse Cancer Cell Resistance to Doxorubicin
by: Shuhui Zhang, et al.
Published: (2020)

Nanomaterials for reversion of multidrug resistance in cancer: a new hope for an old idea?
by: João eConde, et al.
Published: (2013)

Editorial: Targeting autophagy in Cancer Therapy: Focus on small-molecule modulators and new strategies
by: Ryszard Pluta
Published: (2023)

Editorial: New drugs, approaches, and strategies to combat antimicrobial resistance
by: Chandra Kant Singh, et al.
Published: (2023)

Exogenous glutathione reverses meropenem resistance in carbapenem-resistant Klebsiella pneumoniae
by: Juan Yi, et al.
Published: (2023)

Antiangiogenic therapy reverses the immunosuppressive breast cancer microenvironment
by: Wuzhen Chen, et al.
Published: (2021)

Nanoparticles (NPs)-mediated systemic mRNA delivery to reverse trastuzumab resistance for effective breast cancer therapy
by: Zhihui Dong, et al.
Published: (2023)

Nitric Oxide-Mediated Enhancement and Reversal of Resistance of Anticancer Therapies
by: Emily Hays, et al.
Published: (2019)

Nanodrug Delivery in Reversing Multidrug Resistance in Cancer Cells
by: Sonali eKapse-Mistry, et al.
Published: (2014)

Editorial: Utilizing omics strategies to discover new drug targets for cancers
by: Shujun Zhang, et al.
Published: (2024)

PARP inhibitor resistance in breast and gynecological cancer: Resistance mechanisms and combination therapy strategies
by: Nannan Wang, et al.
Published: (2022)

Troglitazone reverses the multiple drug resistance phenotype in cancer cells
by: Gerald F Davies, et al.
Published: (2009)

Inhibition of 6-phosphogluconate Dehydrogenase Reverses Cisplatin Resistance in Ovarian and Lung Cancer
by: Wujian Zheng, et al.
Published: (2017)

Editorial: Thyroid cancer: New perspectives in diagnosis and therapy
by: Rhitajit Sarkar, et al.
Published: (2022)

Reversal reversed? The new consensus on education and training
Published: (2015)

In situ repolarization of tumor-associated macrophages with synergic nanoformulation to reverse immunosuppressive TME in mouse breast cancer for cancer therapy
by: Ruhua Luo, et al.
Published: (2024)

Editorial: Clinical Therapeutic Development Against Cancers Resistant to Targeted Therapies
by: Fanfan Zhou, et al.
Published: (2022)

Carrier-Free Hybrid Nanoparticles for Enhanced Photodynamic Therapy in Oral Carcinoma via Reversal of Hypoxia and Oxidative Resistance
by: Xiao Li, et al.
Published: (2024)

Emerging Significance of Ginsenosides as Potentially Reversal Agents of Chemoresistance in Cancer Therapy
by: Jin-Feng Xu, et al.
Published: (2021)

Application and Prospect of CRISPR/Cas9 Technology in Reversing Drug Resistance of Non-Small Cell Lung Cancer
by: Lu Huang, et al.
Published: (2022)

CircRNA: A new class of targets for gastric cancer drug resistance therapy
by: Ying Zheng, et al.
Published: (2023)

Hypoxia-ameliorated photothermal manganese dioxide nanoplatform for reversing doxorubicin resistance
by: Zhenzhen Chen, et al.
Published: (2023)

RUNX2 Reverses p53-Induced Chemotherapy Resistance in Gastric Cancer
by: Huang Y, et al.
Published: (2023)

Effects of Myristicin in Association with Chemotherapies on the Reversal of the Multidrug Resistance (MDR) Mechanism in Cancer
by: Elisa Frederico Seneme, et al.
Published: (2022)

Sericin nanomicelles with enhanced cellular uptake and pH-triggered release of doxorubicin reverse cancer drug resistance
by: Weihong Guo, et al.
Published: (2018)

Editorial: Targeting oxidative stress in cancer: what is new in the prevention, diagnostic, treatment and prognostic strategies?
by: Qianjin Liao, et al.
Published: (2023)

Reversing ferroptosis resistance by MOFs through regulation intracellular redox homeostasis
by: Chengcheng Wang, et al.
Published: (2023)

Dual-responsive nanoparticles with transformable shape and reversible charge for amplified chemo-photodynamic therapy of breast cancer
by: Wenfeng Jia, et al.
Published: (2022)

Nanoparticles (NPs)-mediated lncMALAT1 silencing to reverse cisplatin resistance for effective hepatocellular carcinoma therapy
by: Ting Wang, et al.
Published: (2024)

Predicting and overcoming resistance to CDK9 inhibitors for cancer therapy
by: Chen Hu, et al.
Published: (2023)

Synergistic Activity of the HSP90 Inhibitor Ganetespib With Lapatinib Reverses Acquired Lapatinib Resistance in HER2-Positive Breast Cancer Cells
by: Min Ye, et al.
Published: (2021)

Reversal of Ovarian Cancer Cell Lines Multidrug Resistance Phenotype by the Association of Apiole with Chemotherapies
by: Carolina Afonso de Lima, et al.
Published: (2020)